Close menu




September 22nd, 2021 | 12:04 CEST

Nordex, PuriflOH, JinkoSolar: Investing in a better world

  • Investments
Photo credits: pixabay.com

To make the world a better place. That is the concern of all entrepreneurs - although one can no doubt argue about innovations in detail. There is no doubt about renewable energy and clean water. Every innovation in these areas pays off not only monetarily but in a variety of ways. We profile three stocks that are doing good.

time to read: 3 minutes | Author: Nico Popp
ISIN: NORDEX SE O.N. | DE000A0D6554 , PURIFLOH LTD | AU0000010548 , JINKOSOLAR ADR/4 DL-00002 | US47759T1007

Table of contents:


    Nordex is slowly gaining momentum

    One of the classic German second-line stocks is Nordex. The wind turbine manufacturer has had an eventful time. The Company has now joined the MDAX and boasts a high order backlog. The trend towards renewable energies is having a positive impact on Nordex. However, a comparatively new industry is often also characterized by significant competition. Nordex is currently not very profitable. At the end of 2020, the EBITDA margin fell to 2% but is expected to be significantly higher in 2021. Specifically, this is due to old projects coming to an end and new projects that are more profitable. Nordex has, therefore, already set the course for a promising future.

    Nordex's stock has taken a beating over the past three months, losing around 12.5%. In the long term, too, the stock is in a sideways trend with a slight downward tendency. Only prices above the EUR 20 mark could turn the tide and make the share look more attractive again. However, as things are progressing operationally and Nordex is in line with the spirit of the times, such a liberation blow cannot be ruled out.

    PuriflOH: Clean water and clean air - this trend is at the beginning

    When we think of a livable future, clean water has a significant role to play. Already, researchers are predicting wars over clean water around the world. In addition to purifying water, the Australian Company PuriflOH also specializes in keeping the air and surfaces clean. Especially in the wake of the pandemic and the greater awareness of health that comes with it, PuriflOH could offer great opportunities. The Company has patented solutions for cleaning the air. Possible targets include public buildings, offices and schools.

    Since PuriflOH is not a newcomer to the pandemic but has invested in its technology for years, now could be the time to take credit. The technology features low energy consumption, longevity and high fault tolerance. At the same time, it is suitable for filtering various biological and chemical contaminants from the air. PuriflOH is in the process of rolling out its technology on a large scale and is talking to potential partners. The Company currently costs only about EUR 30 million. If PuriflOH succeeds in putting its horsepower on the road and scoring points in the market, it could become a major growth story.

    JinkoSolar: The sun shines even after the China crash

    JinkoSolar's stock is also undoubtedly a growth story. The manufacturer of photovoltaic systems has turned the global market around in recent years and now has a significant market share. In terms of longevity and efficiency, JinkoSolar's modules are also the best in the world. But the stock has been staggering for some time. Why? The Evergrande scandal has since been added to the initially somewhat vague China fears.

    According to skeptics, a downturn in the Chinese real estate market could affect the entire economy. In addition, solar systems are primarily mounted on rooftops. If few buildings are built, that could be negative for JinkoSolar's business. Still, there are arguments that the recent sell-off was overdone. JinkoSolar has a good market position and is cheaper today than it was six months ago. The stock is, without a doubt, one of the best sustainable stocks in the world. In the short term, however, it may remain turbulent given the situation in China.


    Nordex has bottomed out, and JinkoSolar is currently available at a risk discount - for investors looking to invest in green stocks, conditions are not that bad. But both Nordex and JinkoSolar are established players in their field - there are usually no big surprises. Those who focus on growth and know how to deal with such stocks should also look at PuriflOH. The technology around the purification of water, air and surfaces is promising. The Company is at the very beginning.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author



    Related comments:

    Commented by André Will-Laudien on January 31st, 2023 | 14:50 CET

    E-mobility 2023: The Tesla hunters are coming! BYD, Lucid Motors, Tocvan Ventures. Will the Varta share now also fly?

    • Mining
    • Gold
    • Electromobility
    • Investments

    It Is hard to believe! The Tesla share is once again making a name for itself. Analysts went into the presentation of the annual figures with cautious expectations because there were many negative rumors surrounding Elon Musk's electronics company: Fewer sales? Cars on stockpile? Again, it came as no one had expected it. Elon Musk delivered and simultaneously mocked all the shorties who wanted to push his stock below USD 100 at the turn of the year. This gambit went badly wrong because Tesla was able to deliver even better figures than expected, and there was no stopping the share. With plus 70% in only 4 weeks, the Tesla share belongs to the shooting stars since the turn of the year - the short sellers must have lost their desire completely. But the variety of interesting shares is significant. Where are the opportunities for e-investors lurking?

    Read

    Commented by Nico Popp on January 31st, 2023 | 14:33 CET

    This new project changes everything: Deutsche Bank, Aspermont, Alibaba

    • Digitization
    • Innovations
    • Technology
    • Investments

    When processes go digital, great opportunities arise: automation and scaling can ensure growth and turn established business models into high-flyers. But which companies should investors actively support in their transformation? Where is there real potential for investors, and where are companies just spreading buzzwords? We highlight three stocks for you.

    Read

    Commented by André Will-Laudien on January 30th, 2023 | 09:13 CET

    Mega biotech rally 2023! Defence Therapeutics, Bayer, BioNTech, Morphosys - Where to put the money?

    • Biotechnology
    • Cancer
    • Covid19
    • Investments

    Who would have thought it? Since the beginning of the year, the stock markets have been jubilant despite difficult predictions about the economic trend in 2023. High inflation and rising interest rates are not a good breeding ground for the popular biotech stocks because they have to constantly refinance their research expenses. As the risk fee is readjusted as costs rise, investors demand higher premiums for providing money. However, some biotech stocks have taken off since the beginning of the year despite adverse conditions. What is their secret?

    Read